COVID-19 Vaccine | Fortune

Skip to Content

SIGN IN

Health
Only one of the Big Four vaccine makers produced a COVID-19 winner. What happens next?
By
Kat Eschner
March 3, 2021
Health
Indian government officials are touting a homegrown vaccine over AstraZeneca’s
By
Grady McGregor
March 3, 2021
Health
Biden set to announce vaccine manufacturing partnership between Merck and Johnson & Johnson
By
Andrew Marquardt
March 2, 2021
Health
Russia’s Sputnik V vaccine is winning over Eastern Europe—but most Russians don’t want it
By
David Meyer
March 2, 2021
International
China sets a goal of vaccinating half a billion people in 5 months. Can it meet the target?
By
Grady McGregor
March 2, 2021
Health
With a new vaccine and fast-spreading variants, U.S. COVID fight becomes a head-to-head race
By
David Z. Morris
March 1, 2021
Health
Biden officials warn Johnson & Johnson vaccine rollout may be slow
By
Andrew Marquardt
March 1, 2021
Health
Narendra Modi receives India’s homegrown—and unproven—COVID-19 vaccine
By
Grady McGregor
March 1, 2021
Health
Anthony Fauci warns against shopping around for your favorite COVID vaccine
By
Michael Riley,
Ros Krasny,
and others
March 1, 2021
Health
I am getting a less effective vaccine now. Can I get a better one later?
By
Grady McGregor
and
Jeremy Kahn
February 27, 2021
Commentary
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
By
Sally C. Pipes
February 26, 2021
Health
Why there is hope the U.S. might avoid the worst of the new COVID-19 variants
By
Geoff Colvin
February 26, 2021
Travel
A ‘fast lane’ for the vaccinated? Europe inches closer to COVID-19 vaccine passports
By
David Meyer
February 26, 2021
Health
Why AstraZeneca and J&J’s vaccines are still on hold in the U.S.
By
Sarah Jane Tribble
and
Kaiser Health News
February 26, 2021

1 - 14 of 149 results

1 - 14 of 149 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.